The government on Friday asked a three-judge panel of the federal appeals court in Manhattan to deny Martoma's bail request, arguing that jurors were given "overwhelming evidence" of Martoma's guilt at his trial. The panel is scheduled to hear arguments on Martoma's bail request November 12.
Martoma, 40, was sentenced to nine years in prison after he was convicted of making $275 million for SAC by using illegal tips to trade in Elan Corp. and Wyeth LLC. He asked the appeals court to grant him bail after the trial judge denied a similar request.
"Martoma has failed to carry his burden of showing that his appeal raises a substantial question of law likely to alter the judgment of conviction, as required for this court to order bail pending appeal," the government said in a court filing.
Martoma, who was scheduled to report to prison November 10, won a temporary delay while the appeals court decides whether to grant him bail.
Bail request
In his bail request, Martoma claimed US District Judge Paul Gardephe made errors during the trial, including excluding testimony by SAC founder Steven Cohen about his own Elan and Wyeth trades. Martoma also faulted the judge for keeping jurors from hearing an expert witness testify that public information showed that Elan was overvalued in July 2008.
Prosecutors claimed Stamford, Connecticut-based SAC liquidated a $700 million position in Elan and Wyeth that month within days after Martoma learned inside information about negative clinical tests on the Alzheimer's disease drug bapineuzumab.
Martoma also claimed the government failed to prove that his source, a physician supervising the bapineuzumab testing, benefited from passing the illegal tips.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
